KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

LifeMD (LFMD) EPS (Weighted Average and Diluted) (2016 - 2025)

Historic EPS (Weighted Average and Diluted) for LifeMD (LFMD) over the last 12 years, with Q3 2025 value amounting to -$0.1.

  • LifeMD's EPS (Weighted Average and Diluted) rose 2307.69% to -$0.1 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.22, marking a year-over-year increase of 6507.94%. This contributed to the annual value of -$0.6 for FY2024, which is 1487.55% up from last year.
  • As of Q3 2025, LifeMD's EPS (Weighted Average and Diluted) stood at -$0.1, which was up 2307.69% from -$0.05 recorded in Q2 2025.
  • Over the past 5 years, LifeMD's EPS (Weighted Average and Diluted) peaked at -$0.02 during Q1 2025, and registered a low of -$0.7 during Q4 2021.
  • Over the past 5 years, LifeMD's median EPS (Weighted Average and Diluted) value was -$0.2 (recorded in 2023), while the average stood at -$0.29.
  • As far as peak fluctuations go, LifeMD's EPS (Weighted Average and Diluted) tumbled by 13703.7% in 2021, and later surged by 8891.09% in 2025.
  • Over the past 5 years, LifeMD's EPS (Weighted Average and Diluted) (Quarter) stood at -$0.7 in 2021, then surged by 41.61% to -$0.41 in 2022, then skyrocketed by 67.6% to -$0.13 in 2023, then fell by 4.33% to -$0.14 in 2024, then increased by 27.92% to -$0.1 in 2025.
  • Its EPS (Weighted Average and Diluted) stands at -$0.1 for Q3 2025, versus -$0.05 for Q2 2025 and -$0.02 for Q1 2025.